Author

Farhan Alam

University of HelsinkiORCID 0009-0003-1089-4810Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:benchmarking· 1 Organism:C. elegans· 1 Research Focus:cell type annotation· 1 Research Focus:database / resource· 1 Research Focus:differential expression· 1 Assay:metabolomics· 1 Organism:mouse· 1

Frequent Co-Authors

Ana Montaño-RodrigueziD· 1 shared Andrea ZalianiiD· 1 shared Carina I. HolmbergiD· 1 shared Charles BrenneriD· 1 shared Eija PirineniD· 1 shared Evgeny KulesskiyiD· 1 shared Florence BiétrixiD· 1 shared Giorgio TurconiiD· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Ana Montaño-RodriguezORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioinformaticsBriefings in BioinformaticsPeer-reviewedAug 9, 2021

Minimal information for Chemosensitivity assays (MICHA): A next-generation pipeline to enable the FAIRification of drug screening experiments

Ziaurrehman Tanoli, Jehad Aldahdooh, Farhan Alam…·Jing Ping Tang

MICHA is a pipeline that FAIRifies chemosensitivity assays by automatically annotating compounds, samples, reagents, and data processing methods, enabling interoperable and reusable drug screening data.

16 citations

experimental assaydatabase / resource

𝕏 PostBluesky

NeurosciencebioRxivPreprintMar 12, 2021

Nicotinamide riboside alleviates Parkinson's disease symptoms but downregulates dopamine metabolism upon lactacystin-induced proteostasis failure

Giorgio Turconi, Farhan Alam, Tanima SenGupta…·Eija Pirinen

This study shows that nicotinamide riboside (NR) alleviates Parkinson's disease symptoms in animal models but reduces dopamine levels when combined with proteasome inhibition.

3 citations

C. elegansmouse

𝕏 PostBluesky